Quick Takeaways
- D. E. SHAW & CO, L.P. filed SCHEDULE 13G/A for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT).
- Disclosed ownership: 1.9%.
- Date of event: 30 Sep 2025.
D. E. SHAW & CO, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT)
- Filing Manager
- D. E. SHAW & CO, L.P.
- Reporting Manager
- D. E. Shaw & Co., L.P.
- Symbol
- SRPT
- Shares outstanding
- 105,632,895 shares
- Disclosed Ownership
- 2,007,025 shares
- Ownership
- 1.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:08:26 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 25 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"D. E. SHAW & CO, L.P. disclosed 1.9% ownership in Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 25 Jul 2025.
- Current filing was accepted on 14 Nov 2025, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., L.P. | 1.9% | 2,007,025 | 0 | 1,984,525 | /s/ Daniel R. Marcus | Daniel R. Marcus / Chief Compliance Officer | |
| David E. Shaw | 1.9% | 2,007,025 | 0 | 1,984,525 | /s/ Daniel R. Marcus | Daniel R. Marcus / Attorney-in-Fact for David E. Shaw |